228 related articles for article (PubMed ID: 34344873)
1. Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system.
Bolaender A; Zatorska D; He H; Joshi S; Sharma S; Digwal CS; Patel HJ; Sun W; Imber BS; Ochiana SO; Patel MR; Shrestha L; Shah SK; Wang S; Karimov R; Tao H; Patel PD; Martin AR; Yan P; Panchal P; Almodovar J; Corben A; Rimner A; Ginsberg SD; Lyashchenko S; Burnazi E; Ku A; Kalidindi T; Lee SG; Grkovski M; Beattie BJ; Zanzonico P; Lewis JS; Larson S; Rodina A; Pillarsetty N; Tabar V; Dunphy MP; Taldone T; Shimizu F; Chiosis G
Nat Commun; 2021 Aug; 12(1):4669. PubMed ID: 34344873
[TBL] [Abstract][Full Text] [Related]
2. The epichaperome is an integrated chaperome network that facilitates tumour survival.
Rodina A; Wang T; Yan P; Gomes ED; Dunphy MP; Pillarsetty N; Koren J; Gerecitano JF; Taldone T; Zong H; Caldas-Lopes E; Alpaugh M; Corben A; Riolo M; Beattie B; Pressl C; Peter RI; Xu C; Trondl R; Patel HJ; Shimizu F; Bolaender A; Yang C; Panchal P; Farooq MF; Kishinevsky S; Modi S; Lin O; Chu F; Patil S; Erdjument-Bromage H; Zanzonico P; Hudis C; Studer L; Roboz GJ; Cesarman E; Cerchietti L; Levine R; Melnick A; Larson SM; Lewis JS; Guzman ML; Chiosis G
Nature; 2016 Oct; 538(7625):397-401. PubMed ID: 27706135
[TBL] [Abstract][Full Text] [Related]
3. Systems-level analyses of protein-protein interaction network dysfunctions via epichaperomics identify cancer-specific mechanisms of stress adaptation.
Rodina A; Xu C; Digwal CS; Joshi S; Patel Y; Santhaseela AR; Bay S; Merugu S; Alam A; Yan P; Yang C; Roychowdhury T; Panchal P; Shrestha L; Kang Y; Sharma S; Almodovar J; Corben A; Alpaugh ML; Modi S; Guzman ML; Fei T; Taldone T; Ginsberg SD; Erdjument-Bromage H; Neubert TA; Manova-Todorova K; Tsou MB; Young JC; Wang T; Chiosis G
Nat Commun; 2023 Jun; 14(1):3742. PubMed ID: 37353488
[TBL] [Abstract][Full Text] [Related]
4. Chaperome heterogeneity and its implications for cancer study and treatment.
Wang T; Rodina A; Dunphy MP; Corben A; Modi S; Guzman ML; Gewirth DT; Chiosis G
J Biol Chem; 2019 Feb; 294(6):2162-2179. PubMed ID: 30409908
[TBL] [Abstract][Full Text] [Related]
5. Chemical probes and methods for single-cell detection and quantification of epichaperomes in hematologic malignancies.
Merugu S; Sharma S; Kaner J; Digwal C; Sugita M; Joshi S; Taldone T; Guzman ML; Chiosis G
Methods Enzymol; 2020; 639():289-311. PubMed ID: 32475406
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Diabetic Chaperome to Improve Peripheral Neuropathy.
Dobrowsky RT
Curr Diab Rep; 2016 Aug; 16(8):71. PubMed ID: 27318486
[TBL] [Abstract][Full Text] [Related]
7. The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction.
Inda MC; Joshi S; Wang T; Bolaender A; Gandu S; Koren Iii J; Che AY; Taldone T; Yan P; Sun W; Uddin M; Panchal P; Riolo M; Shah S; Barlas A; Xu K; Chan LYL; Gruzinova A; Kishinevsky S; Studer L; Fossati V; Noggle SA; White JR; de Stanchina E; Sequeira S; Anthoney KH; Steele JW; Manova-Todorova K; Patil S; Dunphy MP; Pillarsetty N; Pereira AC; Erdjument-Bromage H; Neubert TA; Rodina A; Ginsberg SD; De Marco Garcia N; Luo W; Chiosis G
Nat Commun; 2020 Jan; 11(1):319. PubMed ID: 31949159
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the Mechanism of Epichaperome Modulation by Zelavespib: Biochemical Insights on Target Occupancy and Extended Residence Time at the Site of Action.
Sharma S; Joshi S; Kalidindi T; Digwal CS; Panchal P; Lee SG; Zanzonico P; Pillarsetty N; Chiosis G
Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37892973
[TBL] [Abstract][Full Text] [Related]
9. Chaperome Networks - Redundancy and Implications for Cancer Treatment.
Yan P; Wang T; Guzman ML; Peter RI; Chiosis G
Adv Exp Med Biol; 2020; 1243():87-99. PubMed ID: 32297213
[TBL] [Abstract][Full Text] [Related]
10. Paradigms for Precision Medicine in Epichaperome Cancer Therapy.
Pillarsetty N; Jhaveri K; Taldone T; Caldas-Lopes E; Punzalan B; Joshi S; Bolaender A; Uddin MM; Rodina A; Yan P; Ku A; Ku T; Shah SK; Lyashchenko S; Burnazi E; Wang T; Lecomte N; Janjigian Y; Younes A; Batlevi CW; Guzman ML; Roboz GJ; Koziorowski J; Zanzonico P; Alpaugh ML; Corben A; Modi S; Norton L; Larson SM; Lewis JS; Chiosis G; Gerecitano JF; Dunphy MPS
Cancer Cell; 2019 Nov; 36(5):559-573.e7. PubMed ID: 31668946
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of
Sharma S; Kalidindi T; Joshi S; Digwal CS; Panchal P; Burnazi E; Lee SG; Pillarsetty N; Chiosis G
STAR Protoc; 2022 Jun; 3(2):101318. PubMed ID: 35496791
[TBL] [Abstract][Full Text] [Related]
12. First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer.
Dunphy MPS; Pressl C; Pillarsetty N; Grkovski M; Modi S; Jhaveri K; Norton L; Beattie BJ; Zanzonico PB; Zatorska D; Taldone T; Ochiana SO; Uddin MM; Burnazi EM; Lyashchenko SK; Hudis CA; Bromberg J; Schöder HM; Fox JJ; Zhang H; Chiosis G; Lewis JS; Larson SM
Clin Cancer Res; 2020 Oct; 26(19):5178-5187. PubMed ID: 32366671
[TBL] [Abstract][Full Text] [Related]
13. Global proteomic analyses define an environmentally contingent Hsp90 interactome and reveal chaperone-dependent regulation of stress granule proteins and the R2TP complex in a fungal pathogen.
O'Meara TR; O'Meara MJ; Polvi EJ; Pourhaghighi MR; Liston SD; Lin ZY; Veri AO; Emili A; Gingras AC; Cowen LE
PLoS Biol; 2019 Jul; 17(7):e3000358. PubMed ID: 31283755
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound.
Yang FY; Wang HE; Liu RS; Teng MC; Li JJ; Lu M; Wei MC; Wong TT
PLoS One; 2012; 7(9):e45468. PubMed ID: 23029030
[TBL] [Abstract][Full Text] [Related]
15. Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease.
Blair LJ; Sabbagh JJ; Dickey CA
Expert Opin Ther Targets; 2014 Oct; 18(10):1219-32. PubMed ID: 25069659
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer.
Joshi S; Gomes ED; Wang T; Corben A; Taldone T; Gandu S; Xu C; Sharma S; Buddaseth S; Yan P; Chan LYL; Gokce A; Rajasekhar VK; Shrestha L; Panchal P; Almodovar J; Digwal CS; Rodina A; Merugu S; Pillarsetty N; Miclea V; Peter RI; Wang W; Ginsberg SD; Tang L; Mattar M; de Stanchina E; Yu KH; Lowery M; Grbovic-Huezo O; O'Reilly EM; Janjigian Y; Healey JH; Jarnagin WR; Allen PJ; Sander C; Erdjument-Bromage H; Neubert TA; Leach SD; Chiosis G
Commun Biol; 2021 Nov; 4(1):1333. PubMed ID: 34824367
[TBL] [Abstract][Full Text] [Related]
17. A global view of Hsp90 functions.
Chiosis G; Dickey CA; Johnson JL
Nat Struct Mol Biol; 2013 Jan; 20(1):1-4. PubMed ID: 23288357
[TBL] [Abstract][Full Text] [Related]
18. Chemical Tools to Investigate Mechanisms Associated with HSP90 and HSP70 in Disease.
Shrestha L; Patel HJ; Chiosis G
Cell Chem Biol; 2016 Jan; 23(1):158-172. PubMed ID: 26933742
[TBL] [Abstract][Full Text] [Related]
19. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.
Dickey CA; Kamal A; Lundgren K; Klosak N; Bailey RM; Dunmore J; Ash P; Shoraka S; Zlatkovic J; Eckman CB; Patterson C; Dickson DW; Nahman NS; Hutton M; Burrows F; Petrucelli L
J Clin Invest; 2007 Mar; 117(3):648-58. PubMed ID: 17304350
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation-Driven Epichaperome Assembly: A Critical Regulator of Cellular Adaptability and Proliferation.
McNutt SW; Roychowdhury T; Pasala C; Nguyen HT; Thornton DT; Sharma S; Botticelli L; Digwal CS; Joshi S; Yang N; Panchal P; Chakrabarty S; Bay S; Markov V; Kwong C; Lisanti J; Chung SY; Ginsberg SD; Yan P; DeStanchina E; Corben A; Modi S; Alpaugh M; Colombo G; Erdjument-Bromage H; Neubert TA; Chalkley RJ; Baker PR; Burlingame AL; Rodina A; Chiosis G; Chu F
Res Sq; 2024 Apr; ():. PubMed ID: 38645031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
